Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Data element name

Sub data element name

Value

Code System Owner

Name

US Department of Veterans Affairs; John Kilbourne, MD

Websitehttps://www.va.gov/
Email addressmedrt@jpsys.comJohn.Kilbourne@va.gov 
Phone number
Address
Code System Maintainer (Steward)NameUS Department of Veterans Affairs; John Kilbourne, MD
Websitehttps://www.va.gov/
Email addressmedrt@jpsys.comJohn.Kilbourne@va.gov 
Phone number
Address
Code System PublisherNameNational Cancer Institute (NCI) Enterprise Vocabulary Services (EVS)
Websitehttps://evs.nci.nih.gov/
Email address
Phone number
Address
Code System NamesFormal name of the code system

Medication Reference Terminology (MED-RT)

Short name of the code systemMEDRT
Code System Technical IdentifiersHTA-endorsed URIhttp://va.gov/terminology/medrt
HTA-endorsed OID2.16.840.1.113883.6.345
Other URIs
Other OIDs
Code System InformationLinkhttps://ncit.nci.nih.gov/ncitbrowser/pages/vocabulary.jsf?dictionary=MED-RT
Notes

Medication Reference Terminology (MED-RT™) is the evolutionary successor to the Veterans Health Administration National Drug File – Reference Terminology (VHA NDF-RT™). Both are formal ontology representations of medication terminology, pharmacologic classifications, and asserted authoritative relationships between them.

The MED-RT code system includes relationships between MED-RT concepts and concepts in external code systems, as well as relationships between concepts only in the external code systems. The external code systems that MED-RT references include RxNorm, MeSH, and SNOMED CT US Edition.

MED-RT can be downloaded from https://evs.nci.nih.gov/ftp1/MED-RT/.

Arrangement or agreements with HL7 for use of content
None
Version management
MED-RT is released ten times a year.
Code System Copyright, Intellectual Property and LicensingCopyright Statement
Copyright InformationMED-RT has no copyright acknowledgement required. However, users must adhere to the UMLS license.
Intellectual Property Information
Licensing Information
HTA endorsement statusValueEndorsed for use
Assignment date16Feb22
HTA review statusLast review date16Feb22
Next review date16Feb23
Information current as at (date)
2021100516Feb22